IndraLab

Statements


STAMBPL1 leads to the ubiquitination of SESN2. 1 / 1
| 1

reach
"Consistently, knockout of STAMBPL1 and subsequent increase in Sestrin2 ubiquitination markedly inhibited xenograft tumor growth [119]."